Rank 92 • MedTech & Devices
Mainstay Medical
Manufactures ReActive8, an implantable restorative neurostimulation system designed to treat mechanical chronic low back pain.
Visit website- Signal Score
- 79.8
- Total raised
- $230M
- Stage
- Growth
- Founded
- 2008
- Headquarters
- Dublin, Ireland
- Region
- Europe
Their signal
Targeting the root cause of chronic back pain through muscle rehabilitation rather than masking pain, Mainstay is securing rapid global reimbursement and building strong clinical evidence.
Signal Score 79.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.